Capital Investment Advisors LLC Has $1.17 Million Stake in Zoetis Inc. $ZTS

Capital Investment Advisors LLC reduced its stake in shares of Zoetis Inc. (NYSE:ZTS) by 34.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 9,335 shares of the company’s stock after selling 4,807 shares during the period. Capital Investment Advisors LLC’s holdings in Zoetis were worth $1,174,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Summit Place Financial Advisors LLC grew its holdings in Zoetis by 0.4% during the third quarter. Summit Place Financial Advisors LLC now owns 19,369 shares of the company’s stock worth $2,834,000 after buying an additional 76 shares in the last quarter. First County Bank CT lifted its stake in Zoetis by 5.4% during the 3rd quarter. First County Bank CT now owns 1,535 shares of the company’s stock valued at $225,000 after acquiring an additional 79 shares in the last quarter. CWA Asset Management Group LLC boosted its holdings in Zoetis by 1.1% during the 3rd quarter. CWA Asset Management Group LLC now owns 7,236 shares of the company’s stock worth $1,059,000 after acquiring an additional 80 shares during the last quarter. Balefire LLC boosted its holdings in Zoetis by 3.5% during the 3rd quarter. Balefire LLC now owns 2,463 shares of the company’s stock worth $360,000 after acquiring an additional 84 shares during the last quarter. Finally, Evergreen Capital Management LLC grew its stake in shares of Zoetis by 3.3% in the 3rd quarter. Evergreen Capital Management LLC now owns 2,696 shares of the company’s stock worth $394,000 after acquiring an additional 85 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. HSBC set a $140.00 target price on shares of Zoetis in a report on Wednesday, December 10th. UBS Group set a $136.00 price objective on shares of Zoetis in a research report on Thursday, January 29th. Weiss Ratings lowered shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday. William Blair reissued an “outperform” rating on shares of Zoetis in a research report on Monday, March 2nd. Finally, Bank of America boosted their target price on Zoetis from $135.00 to $140.00 and gave the stock a “neutral” rating in a research note on Friday, February 13th. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $152.91.

Zoetis Stock Performance

Shares of ZTS opened at $113.48 on Monday. Zoetis Inc. has a 1 year low of $113.29 and a 1 year high of $172.23. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. The stock’s fifty day moving average price is $123.39 and its two-hundred day moving average price is $129.03. The firm has a market cap of $47.90 billion, a PE ratio of 18.85, a PEG ratio of 1.73 and a beta of 0.95.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The company had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. During the same quarter in the prior year, the company earned $1.40 EPS. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, equities research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be paid a $0.53 dividend. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.9%. Zoetis’s dividend payout ratio (DPR) is presently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.